Home » Authors » James Etheridge

Articles by James Etheridge

Cerep Completes Drug Target Validation Under 1999 BMS Deal

May 8, 2002

By James Etheridge

Genset Prepares To Initiate Clinical Trials Of Famoxin

May 1, 2002

By James Etheridge

Genset Prepares To Initiate Clinical Trials Of Famoxin

May 1, 2002

By James Etheridge

Faust Pharmaceuticals Obtains $2.6M To Develop CNS Drugs

April 24, 2002

By James Etheridge

Faust Pharmaceuticals Obtains $2.6M To Develop CNS Drugs

April 24, 2002

By James Etheridge

Hybrigenics Raises $14.8M In Third Funding Round

April 17, 2002

By James Etheridge

Start-Up CareX Raises $5.2M In Initial Funding Round

April 17, 2002

By James Etheridge

Start-Up CareX Raises $5.2M In Initial Funding Round

April 17, 2002

By James Etheridge

Hybrigenics Raises $14.8M In Third Funding Round

April 17, 2002

By James Etheridge

Evologic Uses Forced Evolution To Create Microbial Organisms

April 10, 2002

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...